Therapy Areas: Vaccines
Pfizer and Valneva report strong Phase 3 results for Lyme disease vaccine candidate
23 March 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) and French vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) on Monday reported positive topline results from the Phase 3...
Mabtech partners with Sai Life Sciences to expand access to EYRA multiplex immunology platform
19 March 2026 - Swedish life science tools company Mabtech announced on Wednesday a strategic collaboration with Sai Life Sciences, a global Contract Research Organisation (CRO).Under the agreement, S...
Elaris FlexCo signs global licence agreement with Valneva
19 March 2026 - Elaris FlexCo, an Austrian biotechnology company developing vaccines against serious bacterial infections, announced on Wednesday that it has signed a licensing agreement with French v...
ECO Animal Health announces receipt of favourable USDA safety assessment for ECOVAXXIN MG poultry vaccine
11 March 2026 - ECO Animal Health Group plc announced on Wednesday that the United States Department of Agriculture has delivered a favourable safety assessment for its live poultry vaccine ECOVAXXIN ...
Sino Biological launches 2026-2027 Northern Hemisphere influenza vaccine strain antigens
4 March 2026 - Chinese biotechnology company Sino Biological Inc (SZ:301047) announced on Wednesday that it has launched the 2026-2027 Northern Hemisphere influenza vaccine strain antigens to accelera...
Centivax Inc doses first healthy volunteers in Centi-Flu 01 Phase 1A clinical trial
13 February 2026 - Clinical-stage biotechnology company Centivax Inc announced on Thursday that the first participants have been dosed in the company's Phase 1A clinical trial evaluating Centi-Fl...